Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma

MLA

Bertrand Filleul, et al. “Patient Outcome in the Belgian Medical Need Program on Bevacizumab for Recurrent Glioblastoma.” Journal of Neurology, vol. 262, no. 3, Oct. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f110e4b673c2d69ac7431b1549de2ef&authtype=sso&custid=ns315887.

APA

Bertrand Filleul, Jean-François Baurain, Frank Van Fraeyenhove, Anne Rogiers, Lionel D’Hondt, Barbara Stragier, Sylvie Luce, F. Bouttens, Philippe Vroman, Eric Joosens, Bart Neyns, Yves Staelens, Vincent Verschaeve, Johnny Duerinck, Paul Clement, Chantal Andre, & Pol Specenier. (2014). Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma. Journal of Neurology, 262(3).

Chicago

Bertrand Filleul, Jean-François Baurain, Frank Van Fraeyenhove, Anne Rogiers, Lionel D’Hondt, Barbara Stragier, Sylvie Luce, et al. 2014. “Patient Outcome in the Belgian Medical Need Program on Bevacizumab for Recurrent Glioblastoma.” Journal of Neurology 262 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f110e4b673c2d69ac7431b1549de2ef&authtype=sso&custid=ns315887.